---
$id: https://graph.org.ai/products/commodity/51131636
$type: Product
source: UNSPSC
code: "51131636"
title: "Efegatran"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Efegatran

**UNSPSC Code**: 51131636
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protease inhibitor and anticoagulant agent with the molecular formula C21H32N6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, VT0VK2474K chemically known as l-prolinamide, n-methyl-d-phenylalanyl-n-(4-((aminoiminomethyl)amino)-1-formylbutyl)-, (s)- but generally known as efegatran, which bears US NIH Compound Identifier 122267. European Medicines Agency schedules Efegatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06464MIG. The term EFEGATRAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35). Most nations schedule efegatran under HS 29339990 and SITC 51577. As of Q4 2014, EFEGATRAN remains the US FDA Preferred Term for this commodity. Efegatran bears US NLM identifiers UMLS ID C0286590 and NCI Concept Code C72749. SMILES: CNC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C=O.

